Open House Original Rebate Agreements 2023-22 - Sofosbuvir, Velpatasvir, Voxilaprevir (Drug Combination)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 69008582

  Document Type - Tender Notices

Description - The health insurance companies involved are pursuing the goal of concluding discount agreements on the combination of active ingredients sofosbuvir, velpatasvir and voxilaprevir with all suitable pharmaceutical companies in accordance with Section 13 0c (1) SGB V. The contract is concluded as part of the open-house original procedure of the health insurance companies: Individual negotiations about the content of the contract are not conducted, uniform conditions apply. The health insurance companies do not guarantee individual contractual partners any exclusivity. The contract period is a maximum of 24 months starting on September 1st, 2023. The contract ends on August 31, 2025 at the latest,

Gt Ref Id - 69008582

Deadline - Aug 31, 2025